AI assistant
RESMED INC — Director's Dealing 2015
Nov 30, 2015
30071_dirs_2015-11-30_416b932a-08ff-4324-a27b-3e15b07f964c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-11-03
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-03 | ResMed Common Stock | M | 5585 | $25.54 | Acquired | 79872.0894 | Direct |
| 2015-11-03 | ResMed Common Stock | S | 5585 | $58.09 | Disposed | 74287.0894 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-03 | ResMed Common Stock Options | $25.540 | M | 5585 | Disposed | 2016-12-17 | ResMed Common Stock (5585) | Direct |
Footnotes
F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.
F3: Includes 207.2194 shares purchased on October 30, 2015, through ResMed's Employee Stock Purchase Plan.
F4: The number of shares reported in Column 5 is the number of shares beneficially owned as of the date of this filing and takes into account transactions reported on Form 4 since the date of the transaction reported herein.